Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ADILW

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ADILW
日付受信時刻ニュースソース見出しコード企業名
2024/05/1521 : 30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/04/2221 : 30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/04/1021 : 30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/04/0221 : 30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/03/0209 : 00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/02/2823 : 30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/02/1323 : 15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
2024/01/1822 : 30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/12/2023 : 00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/11/3006 : 05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/11/1507 : 02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/3121 : 30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/2521 : 00GlobeNewswire Inc.Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/2505 : 30GlobeNewswire Inc.Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/2021 : 00GlobeNewswire Inc.Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/1923 : 30GlobeNewswire Inc.Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/10/1821 : 00GlobeNewswire Inc.Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/09/2820 : 00GlobeNewswire Inc.Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/09/0521 : 30GlobeNewswire Inc.Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/08/2821 : 30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/08/2321 : 30GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/08/2121 : 30GlobeNewswire Inc.Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/08/0421 : 30GlobeNewswire Inc.Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public FloatNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/07/1121 : 30GlobeNewswire Inc.Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/06/0122 : 00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/05/1221 : 30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/05/1021 : 30GlobeNewswire Inc.Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and BusinessNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/03/3105 : 05GlobeNewswire Inc.Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/03/2122 : 00GlobeNewswire Inc.Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
2023/03/0823 : 00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14thNASDAQ:ADILWAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADILW

最近閲覧した銘柄